250 related articles for article (PubMed ID: 18845330)
1. Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy.
Müller UR; Jutel M; Reimers A; Zumkehr J; Huber C; Kriegel C; Steiner U; Haeberli G; Akdis M; Helbling A; Schnyder B; Blaser K; Akdis C
J Allergy Clin Immunol; 2008 Nov; 122(5):1001-1007.e4. PubMed ID: 18845330
[TBL] [Abstract][Full Text] [Related]
2. Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy.
Müller U; Hari Y; Berchtold E
J Allergy Clin Immunol; 2001 Jan; 107(1):81-6. PubMed ID: 11149995
[TBL] [Abstract][Full Text] [Related]
3. Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations.
Ruëff F; Wolf H; Schnitker J; Ring J; Przybilla B
Allergy; 2004 Jun; 59(6):589-95. PubMed ID: 15147443
[TBL] [Abstract][Full Text] [Related]
4. Medication with antihistamines impairs allergen-specific immunotherapy in mice.
Johansen P; Senti G; Maria Martínez Gómez J; Kündig TM
Clin Exp Allergy; 2008 Mar; 38(3):512-9. PubMed ID: 18081882
[TBL] [Abstract][Full Text] [Related]
5. Sublingual immunotherapy for large local reactions caused by honeybee sting: a double-blind, placebo-controlled trial.
Severino MG; Cortellini G; Bonadonna P; Francescato E; Panzini I; Macchia D; Campi P; Spadolini I; Canonica WG; Passalacqua G
J Allergy Clin Immunol; 2008 Jul; 122(1):44-8. PubMed ID: 18468672
[TBL] [Abstract][Full Text] [Related]
6. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
[TBL] [Abstract][Full Text] [Related]
7. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures.
Jutel M; Pichler WJ; Skrbic D; Urwyler A; Dahinden C; Müller UR
J Immunol; 1995 Apr; 154(8):4187-94. PubMed ID: 7706753
[TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract.
Enrique E; Pineda F; Malek T; Bartra J; Basagaña M; Tella R; Castelló JV; Alonso R; de Mateo JA; Cerdá-Trias T; San Miguel-Moncín Mdel M; Monzón S; García M; Palacios R; Cisteró-Bahíma A
J Allergy Clin Immunol; 2005 Nov; 116(5):1073-9. PubMed ID: 16275379
[TBL] [Abstract][Full Text] [Related]
9. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
10. New developments in the diagnosis and treatment of hymenoptera venom allergy.
Müller UR
Int Arch Allergy Immunol; 2001 Apr; 124(4):447-53. PubMed ID: 11340327
[TBL] [Abstract][Full Text] [Related]
11. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
Amar SM; Harbeck RJ; Sills M; Silveira LJ; O'Brien H; Nelson HS
J Allergy Clin Immunol; 2009 Jul; 124(1):150-156.e1-5. PubMed ID: 19523672
[TBL] [Abstract][Full Text] [Related]
12. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.
Müller U; Akdis CA; Fricker M; Akdis M; Blesken T; Bettens F; Blaser K
J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):747-54. PubMed ID: 9648701
[TBL] [Abstract][Full Text] [Related]
13. Side-effects of allergen-specific immunotherapy: a prospective multi-centre study.
Winther L; Arnved J; Malling HJ; Nolte H; Mosbech H
Clin Exp Allergy; 2006 Mar; 36(3):254-60. PubMed ID: 16499635
[TBL] [Abstract][Full Text] [Related]
14. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
[TBL] [Abstract][Full Text] [Related]
15. Systemic and local reactions of bee venom immunotherapy in Iran.
Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
[TBL] [Abstract][Full Text] [Related]
16. Immunologic response to administration of standardized dog allergen extract at differing doses.
Lent AM; Harbeck R; Strand M; Sills M; Schmidt K; Efaw B; Lebo T; Nelson HS
J Allergy Clin Immunol; 2006 Dec; 118(6):1249-56. PubMed ID: 17157654
[TBL] [Abstract][Full Text] [Related]
17. In vitro testing to diagnose venom allergy and monitor immunotherapy: a placebo-controlled, crossover trial.
Brown SG; Haas MA; Black JA; Parameswaran A; Woods GM; Heddle RJ
Clin Exp Allergy; 2004 May; 34(5):792-800. PubMed ID: 15144473
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety.
Tabar AI; Lizaso MT; García BE; Gómez B; Echechipía S; Aldunate MT; Madariaga B; Martínez A
Pediatr Allergy Immunol; 2008 Feb; 19(1):67-75. PubMed ID: 17651380
[TBL] [Abstract][Full Text] [Related]
19. Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy.
Korošec P; Žiberna K; Šilar M; Dežman M; Čelesnik Smodiš N; Rijavec M; Kopač P; Eržen R; Lalek N; Bajrović N; Košnik M; Zidarn M
Clin Exp Allergy; 2015 Oct; 45(10):1579-89. PubMed ID: 26046807
[TBL] [Abstract][Full Text] [Related]
20. Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial.
Launay O; Roudière L; Boukli N; Dupont B; Prévoteau du Clary F; Patey O; David F; Lortholary O; Devidas A; Piketty C; Rey E; Urbinelli R; Allaert FA; Tréluyer JM; Caumes E;
Clin Infect Dis; 2004 Apr; 38(8):e66-72. PubMed ID: 15095233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
